Cozaar gains renal protection licence

October 21, 2003

Merck Sharpe & Dohme's Cozaar has gained a new UK licence for renal protection in patients with type II diabetes …

Lilly to launch three products in 2003

October 21, 2003

Eli Lilly is to embark on an ambitious product launch schedule over the next two years to overcome the patent …

Bayer open to takeover bids

October 21, 2003

The Chief Executive of Bayer has conceded the company cannot continue alone, and has now declared the company open to …

Alzheimer drugs rationing continues despite NICE guidelines

October 21, 2003

Alzheimer's patients in a quarter of all health authorities are still not receiving the latest medicines despite NICE guidance being …

Europe to mimic US research ‘clusters’

October 21, 2003

New networks of excellence in pharmaceutical research must be established if Europe is to catch up with world leading US …

Crestor approval lifts AstraZeneca

October 21, 2003

AstraZeneca has been boosted by the first regulatory approval in the Netherlands of Crestor, its 'superstatin' cholesterol treatment.The drug is …

OTC advertising regulations to be relaxed

October 21, 2003

A ban on advertising some OTC medicines could be lifted as part of the Government drive to create a patient-centred …

Patients to report drug side-effects to NHS

October 21, 2003

Patients will be able to report adverse reactions to medicines direct to the NHS from next year, the Government has …

AZ launches Zomig nasal spray

October 21, 2003

AstraZeneca has launched a new fast acting nasal spray version of its migraine treatment Zomig.The product is intended to bypass …

The Consumer Age

October 21, 2003
Medical Communications empowered, patients

The growing influence of patient advocacy groups (PAGs) such as the Patients Association is evidence of patient power flexing its …

Shire’s chief steps down

October 21, 2003

Shire's chief executive Rolf Stahel is to stand down after reports of a widening rift with US non-executive directors and …

Elan running $1bn loss

October 21, 2003

Elan reported a net loss of $1 billion for the third quarter, following charges of $943 million.A significant portion of …

Bayer healthcare chief quits

October 21, 2003

The head of Bayer's healthcare unit, Frank Morich, has resigned as troubles at the German company continue.Bayer is cutting back …

Latest content